Mds At Dana-Farber Cancer Institute

MDS at Dana-Farber Cancer Institute

MDS Foundation, Inc.

Stem cell transplant beneficial for older patients with myelodysplastic syndrome

Dana-Farber Cancer Institute

The Inaugural Edward P. Evans Seminar in MDS

Dana-Farber Cancer Institute

Edward P. Evans Seminar in MDS, 2021

Dana-Farber Cancer Institute

Promising approaches and clinical trials in MDS

VJHemOnc – Video Journal of Hematology & HemOnc

A Virtual Tour of Dana-Farber Cancer Institute – Longwood Campus

Dana-Farber Cancer Institute

Maximilian Stahl, MD, Adult Leukemia and MDS

Dana-Farber Cancer Institute

Emerging Experts: A Discussion With Tarantino on HER2-Low Breast Cancer and Antibody-Drug Conjugates

Targeted Oncology

Dana Farber Cancer Institute: Imagine

Topics of interest in MDS: the role of maintenance therapy, immune checkpoints & VEN-AZA in HR-MDS

VJHemOnc – Video Journal of Hematology & HemOnc

Evan Chen, MD, Adult Leukemia Physician | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

The unmet needs in low-risk MDS

VJHemOnc – Video Journal of Hematology & HemOnc

Dana-Farber Cancer Institute: Possible

Lachelle Weeks, MD, PhD, Leukemia Physician & Researcher | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Rahul Vedula, MD on leukemia and MDS care and research

Dana-Farber Cancer Institute

Michael Serzan, MD, Genitourinary Cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Immune therapy approaches in MDS

VJHemOnc – Video Journal of Hematology & HemOnc

Laurie Glimcher, MD, of Dana-Farber Cancer Institute - FII Institute Series #FIIHealthIsWealth

State of the art: MDS

VJHemOnc – Video Journal of Hematology & HemOnc